Official announcements
Recall
|
Medicines
|
01/09/2023
Recall due to increased release of active ingredient
Recall
|
Medicines
|
21/08/2023
Recall due to contamination with salbutamol
messages in brief
|
21/08/2023
On Friday 18.8.2023 a delegation of the Chinese Drug Administration Zhejiang Medical Products Administration visited the AGES Medical Market Surveillance for an exchange and deeper insights into the fields of activity.
Recall
|
Medicines
|
18/08/2023
Recall due to possible particles
Recall
|
Medicines
|
17/08/2023
Recall due to slightly increased peroxide number
Recall
|
Medicines
|
02/08/2023
Recall due to possible contamination with midazolam
CHMP Monthly News
|
01/08/2023
Up-to-date information from the 17.07.-20.07.2023 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
Safety warnings
|
messages in brief
|
01/08/2023
10 years after the review of iron-containing drugs for intravenous use associated with allergic reactions, cautions are recalled.
Recall
|
Medicines
|
21/07/2023
Recall due to nitrosamine contamination above the permitted daily dose
Recall
|
Medicines
|
14/07/2023
Recall due to insufficient active substance release